PT - JOURNAL ARTICLE AU - ANTONIOS KOUTRAS AU - ANGELIS PETEINARIS AU - SPYRIDON DAVAKIS AU - GEORGIOS KALINTERAKIS AU - IOANNIS TSILIKIS AU - NIKOLAOS GARMPIS AU - PROKOPIS-ANDREAS ZOTOS AU - ATHANASIOS CHIONIS AU - DIMITRIOS SCHIZAS AU - IOANNIS KARAVOKYROS AU - NIKOLAOS THOMAKOS AU - EMMANUEL KONTOMANOLIS AU - ATHANASIOS SYLLAIOS TI - Surgical <em>Versus</em> Conservative Treatment for Endometrial Cancer in Women of Reproductive Age: Incidence of Urinary Tract Symptoms AID - 10.21873/anticanres.14287 DP - 2020 Jun 01 TA - Anticancer Research PG - 3065--3069 VI - 40 IP - 6 4099 - http://ar.iiarjournals.org/content/40/6/3065.short 4100 - http://ar.iiarjournals.org/content/40/6/3065.full SO - Anticancer Res2020 Jun 01; 40 AB - Endometrial cancer is the most common gynecologic malignancy. The mainstay of treatment for endometrial cancer is total hysterectomy with bilateral salpingo-oophorectomy. Radiation and chemotherapy accompanied with progestins can also play a significant role in treatment. Lower urinary tract symptoms (LUTS) following therapy for endometrial cancer are an extremely difficult and challenging condition that deteriorates patients' quality of life. Current literature remains rather scarce regarding LUTS after therapy for endometrial cancer. This review aimed to investigate the incidence of LUTS in endometrial cancer treatment.